When “Classical Superiority” Becomes a Scientific Standard: Verifiable Quantum Advantage, Baselines, and the Benchmark Theater

The “superiority” trap in quantum R&D

Imagine a quantum experiment that looks like a win in a chart--but only if you accept the fine print about baselines, how the problem is defined, how runtime is counted, and how “verification” is performed. That fine print is not academic. In research programs, the evidence standard you choose quietly decides which experiments get funding and which get deprioritized.

This is where the idea of verifiable quantum advantage matters. The core claim behind “verifiable quantum advantage” is that quantum performance can be demonstrated in a way that lets observers check correctness using quantum-to-quantum verification rather than trusting a black-box classical simulator or a hand-wavy statistical argument. That framing forces a research question that most benchmark comparisons avoid: can we verify the output in a manner that is both reproducible and harder to game than a single “time-to-solution” headline? (Source)

But verification is only half the story. Classical superiority is also an engineering contest about baselines. A device can appear “superior” if the classical comparison is too weak, too slow (or miscounted), or solves a different problem definition. When classical baselines are treated as an afterthought, “advantage” becomes an artifact of measurement rather than an attribute of the experiment.

So the real target is not quantum versus classical in the abstract. It’s how evidence is produced: the baselines, the timing metrics, the verification mechanics, and the reproducibility of the benchmark itself. Those are the mechanisms behind the “black box,” and they are where “non-verifiable benchmark theater” can hide.

Research integrity is the invisible constraint

The scientific method is not just a lab practice; it’s an institutional design. In public research funding ecosystems, integrity policies exist to manage misconduct risk, but they also shape how evidence is expected to be documented and reproduced. For investigators, that matters because “quantum advantage” claims sit at the boundary between experimental data and benchmark interpretation.

NIH’s research misconduct framework defines research misconduct and lays out expectations for responsible conduct and reporting, including institutional requirements for clear processes for allegations and investigation. While misconduct policy is not specific to quantum benchmarking, it directly affects how researchers document methods and retain evidence, especially when claims are controversial or hard to reproduce. (Source)

NIH also provides detailed guidance on scientific integrity, including a “Final NIH Scientific Integrity Policy” with requirements for reporting, review, and protections around integrity concerns. In other words, the integrity infrastructure a team operates under influences whether benchmark claims are treated as testable hypotheses or rhetorical demonstrations. (Source)

For teams pursuing verifiable quantum advantage, the implication is straightforward: your benchmark is credible only if you preserve, share, and reproduce the evidence chain that leads to the “win.”

What verifiable quantum advantage tries to fix

“Verifiable quantum advantage” aims to replace a fragile evidence chain with a checkable one. As described in the referenced work, it uses quantum-to-quantum verification: a second quantum computation (or quantum process) checks properties of the first computation’s output in a way that reduces reliance on an intractable classical simulation for correctness. (Source)

Practically, that shifts verification away from mere “statistical similarity.” Many quantum benchmarking claims lean on whether output distributions resemble theoretical targets. That approach is vulnerable to mis-specified statistical tests, unknown parameter choices, or selection bias in what tests are reported. With verifiable quantum advantage, the benchmark is designed so the verification step is grounded in the computational structure, making it closer to a logical check than a post hoc fit.

Still, quantum-to-quantum checking isn’t magic. It depends on assumptions: the verifier must be designed so it correlates with the correctness notion being claimed, and both circuits must be executed under comparable conditions. If the verifier is too weak, incorrect outputs can pass. If it’s too costly, the advantage may vanish once verification runtime is included in time-to-solution accounting.

That’s why “classical superiority” must be treated as a full pipeline metric, not a single measurement. The right question becomes: when you count the verification step and enforce matching problem definitions, does the classical baseline still fail in the same way?

Baselines are where benchmarks fail first

Quantum benchmarking often gets reduced to one sentence: “classical simulations are too slow.” It can be true, but it’s scientifically incomplete. “Too slow” depends on baselines, hardware assumptions, and the problem mapping. Two groups can report the same quantum device performance yet reach different conclusions if their classical baselines differ along any of those dimensions.

To investigate properly, baselines need precise mapping, including:

• Classical solver identity and configuration (algorithm family, parameter choices, and whether optimizations are included).
• Classical computing resources, including GPU clusters, CPU counts, and whether the comparison uses real measured performance or extrapolated scaling.
• The unit of comparison: time-to-solution, wall-clock time, number of samples, or total compute for a fixed correctness target.
• Problem definition alignment: whether both solvers compute the same distribution, the same circuit family, or merely comparable tasks.

Even “time-to-solution” can slide. If a benchmark reports time-to-solution for the quantum device but reports only “simulation runtime” for classical methods without matching the number of samples required for an equivalent verification level, the comparison stops being apples-to-apples.

Error mitigation and robustness change the ledger

Quantum advantage claims also hinge on error mitigation and robustness. But “error mitigation” isn’t a single knob--it’s a set of accountable choices that changes (1) which errors dominate, (2) what verification actually tests, and (3) how many experimental samples you need before verification reports “success.”

Error mitigation typically changes benchmarks in measurable ways:

1. Accuracy-throughput coupling. Mitigation can increase effective variance (e.g., by rescaling or reweighting counts), which increases the number of shots required to reach a fixed success criterion. If the benchmark reports a smaller quantum time-to-solution by excluding that extra sample requirement--or by keeping the classical baseline’s sample count fixed--the “advantage” becomes a sampling accounting artifact rather than an implementation advantage.

2. Definition drift between “similarity” and “correctness.” A claim can look strong under distributional similarity metrics while failing under a verifier that encodes a different correctness predicate. Error mitigation shifts the boundary between these two notions. If the paper’s verification success criterion isn’t the same criterion used to tune mitigation parameters (or if it changes between tuning and reporting), outsiders can’t tell whether the improvement reflects robust correctness or post hoc calibration.

3. Mismatch sensitivity to the noise model used for mitigation. Many mitigation methods depend on nuisance assumptions (noise model structure, drift rates, or calibration state quality). Robustness isn’t just “it still works with noise.” It’s how much verifier success degrades when mitigation inputs are perturbed within realistic uncertainty bands. If mitigation hyperparameters are chosen to maximize success at one operating point, reported advantage may disappear under perturbations expected in independent re-runs.

Error mitigation can be part of near-term advantage--but it has to be treated as part of the evidence chain, not a footnote. Otherwise, benchmarks confuse “enhanced output appearance” with “verification-passing correctness.”

For decision-making, interpret “advantage” through a mitigation-inclusive, verification-complete pipeline:

• Verification-inclusive runtime definition: time-to-solution must include mitigation compute (any classical preprocessing/postprocessing), mitigation execution time (if done online), verifier execution time, and preprocessing/postprocessing overhead needed to produce verifiable outputs.
• Sample-count accounting tied to verification: specify how many raw shots are required to achieve a target verifier acceptance probability (or a target error bar on verifier statistics), and show whether the classical baseline is matched on the same success criterion.
• Robustness under calibration perturbations: report results across a small set of mitigation-input perturbations (even coarse), such as ±X% drift in calibration parameters or deliberate mismatch in the assumed noise model class. If the paper can’t define these perturbations, it isn’t yet a decision-grade robustness report--it’s a single-point demonstration.

Baseline mapping decides the comparison spec

A rigorous “classical superiority” standard depends on a comparison specification that can be independently reconstructed. This is where quantum benchmarking often fails: it gives the quantum-side circuit but leaves the classical-side solver as a black box. That may be understandable operationally, but it undermines the benchmark’s scientific function.

The benchmark must state the classical baseline so a third party can re-run it or at least reproduce the performance envelope. That includes whether classical solvers use GPU accelerators versus CPU-only compute, whether tensor network methods are involved, and whether classical inference is exact or approximate. If a baseline uses approximations, its error model must be stated, and the comparison must reflect what those approximations mean relative to the benchmark’s correctness definition.

Time-to-solution is also a specification problem, not just a reported number. For comparisons to be credible, the benchmark should define:

1. the target correctness threshold (what counts as “success”),
2. how many samples are required to reach that threshold,
3. whether verification is included, and
4. how runtimes are measured, including I/O and preprocessing.

Without those details, “verifiable quantum advantage” can’t be truly verified by outsiders, even if a paper claims the advantage is “verifiable” in principle.

Verification mechanics must be checkable

Even with a verification scheme, the question “what is being verified?” must be precise. Verification can mean several things:

• Verification of output correctness with respect to a target distribution.
• Verification of circuit properties or constraints that correlate with correctness.
• Verification of an encoding/decoding relation used to define the output.

Quantum-to-quantum verification strengthens the chain by reducing dependency on classical simulators. But it doesn’t automatically guarantee that the verifier checks the property you care about. It’s possible to have a verifier that is easy to satisfy but not strongly coupled to correctness, especially in adversarial or implementation-biased settings.

So “verification mechanics” should be evaluated in concrete dimensions that can be checked:

1. Completeness–soundness coupling (operational version). The benchmark should state what verifier acceptance probability is expected when the quantum device is correct (completeness) and what acceptance probability upper bound applies when it is wrong but still passes obvious constraints (soundness). Even without formal proofs, it should provide an empirical characterization--such as how acceptance changes under controlled fault injections, circuit perturbations, or deliberate output corruption. Without that characterization, a reviewer can’t tell whether the verifier is discriminative or merely permissive.

2. Independence from knowing the answer. Verification should not rely on calibration inputs that leak the target or on tuning using post hoc selection on which runs “pass.” If the verifier uses measured parameters, those parameters must be frozen before checking starts--or the paper must declare and justify adaptive procedures. Outsiders should reproduce the same acceptance test without accessing hidden selection logic.

3. Stability under experimental drift and circuit perturbations. Reproducibility means the acceptance criterion should remain stable across drifts between runs (gate errors, calibration state reuse windows, parameter remapping). Verification procedures must be stable against drift. If verifier acceptance swings wildly due to minor, unreported calibration changes, “verifiability” collapses into “operational luck.”

These issues align with integrity and governance mechanisms meant to manage evidence quality across funding cycles. In the UK, UKRI’s annual statement on research integrity 2024 describes expectations and the broader research integrity landscape, including governance, accountability, and how integrity risks are addressed across research activities. While not quantum-specific, it reinforces that evidence must be auditable, not merely persuasive. (Source)

The practical recommendation is to build a “benchmark dossier” that includes complete classical baselines, exact time-to-solution accounting, and a test plan for verification stability. Treat incomplete baseline descriptions as a methodological flaw, not a stylistic choice.

Peer review reality: from experiment to claim

Peer review is often described as a quality filter. In quantum benchmarking, it also becomes a filter for interpretability. Reviewers have to decide whether an “advantage” claim rests on a testable standard or on choices that are hard to reconstruct.

That’s where institutional expectations around scientific integrity become operational. NIH’s “expectations policies requirements” for research misconduct outlines expectations for responsible conduct and adherence to policies, affecting how investigators document procedures and respond to concerns. In a field where benchmarking decisions can be contentious, documentation quality becomes part of scientific credibility. (Source)

NIH’s Scientific Integrity Policy further spells out formal mechanisms and protections around scientific integrity matters. For investigators, that means research claims made under grant support come with accountability systems that require evidence handling and reporting. (Source)

Peer review also intersects with how funders frame objectives. NSF’s public communications emphasize keeping scientific research and innovation cutting, while sitting within broader governance priorities. NSF’s “Keeping Us Scientific Research Innovation Cutting” (2025) provides context for how NSF frames scientific research as a national capability, along with expectations about responsible research ecosystems. (Source)

These documents don’t tell you how to set classical baselines for quantum benchmarking. They do, however, signal what reviewers and institutions will increasingly demand: auditability, reproducibility, and clear documentation of methods and evidence.

A decision-grade evidence chain

Translate verification and baseline mapping into an evidence chain that supports roadmap decisions. The chain should have three links:

• Evidence of verified correctness under a defined verification procedure.
• Evidence that classical baselines are competitive under matched time-to-solution and problem definitions.
• Evidence of robustness under error mitigation/robustness settings relevant to near-term hardware.

If any link is weak, “classical superiority” shouldn’t be treated as a decisive stop-go signal. It may still be useful for research, but it must not become a funding guarantee.

This aligns with broader scientific policy discourse around integrity in the global research ecosystem. OECD’s report on integrity and security in the global research ecosystem discusses how integrity mechanisms and governance affect the reliability of research outputs and how threats and failures can undermine trust. The actionable interpretation: don’t treat “trust” as a substitute for verifiable evidence design. (Source)

So the “so what” for a research team is simple: build roadmaps around verifiable metrics, not publication-ready narratives. If your next milestone can’t be verified with your proposed verifier and can’t be reproduced with specified classical baselines, it isn’t a roadmap milestone--it’s a demonstration.

Concrete milestones for usable progress

A common roadmap mistake is treating fault tolerance as the only gate. That’s too narrow. Near-term quantum progress depends on verifiable quantum advantage metrics and also on reproducibility. Reproducibility isn’t “nice to have.” Without it, benchmarks can’t guide engineering tradeoffs.

Fault tolerance milestones should connect to specific evidence outcomes--for example, improvements that reduce the need for heavy error mitigation while maintaining verified correctness. Even if full fault tolerance is far off, roadmaps can define intermediate targets such as reducing the verification failure rate or stabilizing verification under noise drift. Each milestone should specify: (i) the verification acceptance criterion, (ii) the expected failure modes, and (iii) which pipeline parts are allowed to change.

Not all “progress” strengthens a verifiable-advantage claim. A roadmap should distinguish:

• Pipeline progress (evidence-strengthening): changes that improve the verifier’s discriminating power or reduce verification overhead--such as a verifier redesign that increases completeness or tightens soundness gaps, or a mitigation update that improves shot efficiency without altering the correctness predicate.
• Accuracy progress (but not necessarily decision-grade): changes that improve similarity-to-target metrics while leaving verifier acceptance unchanged. These may matter for engineering, but they shouldn’t be treated as confirmation of quantum advantage.
• Operational progress (risk of non-comparability): changes that improve results for a narrow lab configuration (for example, a specific calibration window) without documenting how independent re-runs match the success criterion.

Benchmark reproducibility should be treated like manufacturing quality. That means standardized benchmark scripts, versioned circuit definitions, and a published classical baseline specification. If a classical baseline isn’t reproducible by third parties, it becomes impossible to interpret whether quantum improvements are genuine. In practice, require that a third party can reproduce at least three artifact layers: the circuits, the verifier success-check procedure, and the time-to-solution accounting logic (including sample-count rules). A “re-run” that reproduces circuits but not the accounting is still benchmark theater.

Error mitigation and robustness should be handled the same way. If advantage depends on a narrow error mitigation configuration that’s difficult to re-tune, the benchmark won’t function as an engineering tool. Instead of demanding perfect robustness, define robustness as a tolerance band: specify acceptable perturbations in calibration inputs, noise-model parameters used by mitigation, or drift intervals--and require the same verifier acceptance criterion to hold. If teams can’t state these tolerance bands, then the roadmap milestone isn’t measurable.

Two governance-linked evidence cases

To ground the stakes, consider two governance-linked cases that shape how evidence can be claimed and trusted in research systems.

Case 1: NIH scientific integrity policy implementation.

Timeline: NIH released a “Final NIH Scientific Integrity Policy” in 2024 (as reflected in the document’s posted date) and it sets requirements for scientific integrity processes. Outcome: it formalizes expectations and mechanisms for handling scientific integrity concerns, which in practice pushes labs to document evidence chains more rigorously when claims are contested. Source: the Final NIH Scientific Integrity Policy PDF. (Source)

Case 2: OECD integrity and security in the global research ecosystem report.

Timeline: OECD published the report in 2022 and it addresses integrity and security across the research ecosystem. Outcome: it documents systemic integrity vulnerabilities that can undermine trust in research outputs, reinforcing that investigators and institutions should design evidence for auditability and reliability rather than relying on credibility assertions. Source: OECD report PDF. (Source)

These aren’t quantum benchmark case studies. They are decision-grade realities for researchers: quantum advantage claims depend on institutions that treat integrity and auditability as part of the research output.

Target next applications with constraints

The question “what application classes could be targeted next” often gets answered with broad hopes. A better approach is constraint-based thinking: which problem families allow verifiable checks without making verification so expensive that advantage evaporates?

In decision terms, an application class is “realistic next” if:

• the verifier can check correctness with manageable overhead,
• classical baselines can be specified and run under matched time-to-solution,
• the problem definition stays stable across experiments, and
• error mitigation doesn’t dominate runtime to the point that advantage disappears.

Verifiable quantum advantage becomes a filtering mechanism here. It doesn’t just prove capability--it limits benchmark theater by forcing verification and baseline accounting requirements.

Where funding and policy enforce standards

R&D roadmaps don’t get built in a vacuum. Funders, review panels, and institutional policies define what counts as reliable evidence. When benchmark claims are hard to validate, funders and reviewers become more dependent on transparent documentation and reproducibility.

NIH’s notice on policy and compliance expectations around research misconduct and the scientific integrity environment sets a formal boundary for acceptable evidence practices. That boundary shapes how investigators handle data, methods, and reporting. (Source)

NSF updates on priorities also show how research ecosystems evolve, and investigators must track how funding expectations shift. While these priorities are not quantum benchmarking standards, they establish governance context for why verification, reproducibility, and evidence transparency matter. (Source)

There’s also global governance through research assessment and publication ethics. UNESCO’s work on science reporting and on the freedom and safety of researchers reflects the policy environment that supports inquiry and the conditions under which research can be conducted and trusted. Those frameworks influence how researchers plan for evidence reporting and protection against undue pressure. (Source)

Finally, research capability is increasingly tied to how countries measure R&D activity. UNESCO’s launch of a 2025 survey on R&D statistics for SDG 95 signals that reporting infrastructure remains a policy focus, because measurement systems affect how research systems are managed and evaluated. That measurement infrastructure indirectly matters for benchmarks too: it governs what gets counted and how research performance is assessed across institutions. (Source)

Treat the policy layer as a practical requirement: design evidence as a compliance-ready deliverable. In grant proposals and benchmark reports, build the evidence chain so it survives integrity scrutiny and peer review reconstruction, not just lab demonstration.

Quantitative anchors you should demand

To make the debate operational, investigators should demand quantifiable elements in any quantum advantage claim--not just device performance, but measured time-to-solution under a defined success criterion, plus an explicit breakdown of overheads from verification and error mitigation.

Quantitative anchors to demand from any benchmarking report include:

1. A complete time-to-solution definition, including sample count and verification overhead.
2. A baseline specification with solver configuration and compute resources, such as GPU versus CPU implementations and cluster sizing assumptions.
3. An uncertainty quantification plan for verification statistics, including how many repeated runs are needed.

Even though the provided sources aren’t a quantitative quantum-benchmark dataset, they supply quantitative governance context that can translate into research accountability. For example, the NSF “WTRF” document (as linked) indicates that NSF reports on “Women, Minorities, and Persons with Disabilities in Science and Engineering” with a defined scope and published structure for tracking participation outcomes. That signals NSF treats quantitative, auditable metrics as part of public accountability. While not quantum-benchmark metrics, it reinforces that funder ecosystems increasingly expect numbers with traceable definitions. (Source)

In the same spirit, NIH’s integrity and misconduct documentation expects structured processes rather than vague assurances. Again, not quantum-specific, but it provides a governance model: evidence needs to be measurable, traceable, and actionable. (Source)

Three lab data points to track

Because the goal is decision-grade guidance, track your own benchmark numbers with at least:

• Verification failure rate under the verifier design (per run or per batch). Record it as a percentage with confidence intervals.
• Total time-to-solution including verification and mitigation. Use wall-clock time and include preprocessing and postprocessing overhead.
• Classical baseline throughput for the specified problem definition. Record measured throughput (not only extrapolated scaling) and state whether GPU or CPU resources are used.

The sources provided here support the institutional logic for traceable evidence. The operational numbers above are what your team collects to make “verifiable quantum advantage” more than a label.

If you can’t measure these quantities consistently across runs, you don’t yet have a benchmark you can use for roadmap decisions. You have a demo, not a standard.

Four requirements for reproducible benchmarks

A verifiable quantum advantage program should be reproducible the same way good experimental physics is reproducible: by controlling what can vary and by documenting what was chosen.

From an investigator’s perspective, four requirements are non-negotiable:

1. Baseline reproducibility: the classical solver environment and parameters must be fully specified, including time-to-solution accounting.
2. Problem-definition stability: the circuits and output targets must be exactly defined so “similarity to a target” is not substituted for a specific correctness check.
3. Verifier transparency: the quantum-to-quantum verification logic must be described enough for others to understand what correctness property is being checked.
4. Robustness reporting: error mitigation settings and observed stability under noise drift must be reported so “advantage” can be interpreted as robust, not fragile.

These requirements align with institutional integrity expectations that emphasize documentation and accountability in publicly funded research contexts. NIH’s research misconduct expectations and its scientific integrity policy framework reinforce that evidence practices are not optional. (Source; Source)

Peer review will likely push for these elements because verifiable quantum advantage claims are inherently contested. Without these requirements, reviewers can only rely on trust. That isn’t a scientific standard.

Four real-world cases where evidence matters

Beyond policy, research ecosystems have historical touchpoints where evidence standards and integrity mechanisms affected outcomes. The provided sources give two explicit governance cases above, plus two additional governance-linked references shaping how research reporting and integrity are handled:

• UKRI’s annual research integrity statement for 2024: documents how integrity is addressed across research activities, setting expectations for transparency and responsible conduct. Outcome: increases the organizational baseline for auditability. (Source)
• National Academies “The State of the Science” (2025): frames how science is assessed and communicated, influencing how evidence standards are interpreted by the broader scientific community. Outcome: shapes what “credible” evidence looks like at the system level. (Source)

Verification isn’t only an algorithmic step. It’s an institutional culture. A benchmark that cannot be audited won’t reliably drive roadmaps.

Conclusion: make “advantage” auditable now

Verifiable quantum advantage changes the instinct behind “classical superiority”--it turns a narrative claim into an auditable evidence chain. That only works if classical baselines are specified precisely, time-to-solution is counted in a verification-complete way, and error mitigation and robustness are reported with the same seriousness as the quantum circuit.

If you want this standard to stick, demand the dossier-level detail that lets someone else rerun the benchmark, verify success, and trust the result for the right reasons.